Targeting the JAK/STAT3 pathway with ruxolitinib for RDEB-cSCC therapy

Joanna Jackow

0 views

0 downloads

Powered by

Discover more research and events on morressier.com

Imprint Terms of Service Privacy Policy Accessibility